data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Vyant Bio
(NASDAQ:VYNT)
$0.8207
-0.0893[-9.81%]
At close: Jul 1
$0.95
0.1293[15.75%]
After Hours: 5:42PM EDT
Day High/Low0.8 - 0.89
52 Week High/Low0.6 - 3.88
Open / Close0.88 / 0.82
Float / Outstanding27M / 29.4M
Vol / Avg.25.2K / 526.1K
Mkt Cap24.1M
P/E0.68
50d Avg. Price0.79
Div / Yield-
Payout Ratio-
EPS-1.03
Total Float27M

Vyant Bio (NASDAQ:VYNT), Quotes and News Summary

Vyant Bio (NASDAQ: VYNT)

Day High/Low0.8 - 0.89
52 Week High/Low0.6 - 3.88
Open / Close0.88 / 0.82
Float / Outstanding27M / 29.4M
Vol / Avg.25.2K / 526.1K
Mkt Cap24.1M
P/E0.68
50d Avg. Price0.79
Div / Yield-
Payout Ratio-
EPS-1.03
Total Float27M
Benzinga - Jun 6, 2022, 6:33AM
Benzinga - May 17, 2022, 6:09AM
Benzinga - May 16, 2022, 8:37AM
Benzinga - Apr 11, 2022, 6:06AM
Benzinga - Mar 30, 2022, 8:48AM
Benzinga - Mar 30, 2022, 7:51AM
Benzinga - Mar 30, 2022, 6:16AM
Benzinga - Mar 29, 2022, 5:01PM
Benzinga - Mar 8, 2022, 6:21AM
Benzinga - Mar 1, 2022, 8:53AM
Benzinga - Nov 18, 2021, 7:02AM
load more
Sector: Health Care.Industry: Biotechnology
Vyant Bio Inc is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. Its Central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. The company's platform is designed to elucidate disease pathophysiology; formulate key therapeutic hypotheses; identify and validate drug targets, cellular assays, and biomarkers to guide candidate molecule selection; and guide clinical trial patient selection and trial design. The company derives prime revenue from the U.S.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-15
REV
Q1 2022Est.ActualSurprise
EPS-0.160-0.150 0.0100
REV300.000K303.000K3.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Vyant Bio Questions & Answers

Q
How do I buy Vyant Bio (VYNT) stock?
A

You can purchase shares of Vyant Bio (NASDAQ: VYNT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Vyant Bio's (VYNT) competitors?
Q
What is the target price for Vyant Bio (VYNT) stock?
A

The latest price target for Vyant Bio (NASDAQ: VYNT) was reported by HC Wainwright & Co. on Tuesday, May 17, 2022. The analyst firm set a price target for 3.00 expecting VYNT to rise to within 12 months (a possible 265.54% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Vyant Bio (VYNT)?
A

The stock price for Vyant Bio (NASDAQ: VYNT) is $0.8207 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Vyant Bio (VYNT) pay a dividend?
A

There are no upcoming dividends for Vyant Bio.

Q
When is Vyant Bio (NASDAQ:VYNT) reporting earnings?
A

Vyant Bio’s Q2 earnings are confirmed for Monday, August 15, 2022.

Q
Is Vyant Bio (VYNT) going to split?
A

There is no upcoming split for Vyant Bio.

Q
What sector and industry does Vyant Bio (VYNT) operate in?
A

Vyant Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.